17 Aug COVID-19 Vaccine Janssen: Risk of Thrombosis in combination with Thrombocytopenia
Posted at 12:27h
in
Janssen Pharmaceutica (Pty) Ltd, as directed by the South African Health Products Regulatory Authority (SAHPRA) would like to inform you about the risk of thrombosis in combination with thrombocytopenia, associated with the use of COVID-19 Vaccine Janssen
2021 Nov
Download latest version
Document Number:
DHCPL
Version:
1
Date Updated:
18/11/2021
File Type:
pdf
Category:
Communication To Health Care Professionals